Glycated haemoglobin and the incidence of end-stage renal disease in diabetics

Se Won Oh, Yong Chul Kim, Ho Seok Koo, Dong Chan Jin, Ki Young Na, Dong Wan Chae, Suhnggwon Kim, Ho Jun Chin

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background. The relationship between glycated haemoglobin and the incidence of end-stage renal disease (ESRD) in patients with diabetes remains uncertain, especially in those with decreased glomerular filtration rate (GFR). The aim of this study was to assess the appropriate HbA1c level for diabetics for minimizing the incidence of ESRD and all-cause mortality.Methods. A cohort of patients aged 25 years or older who had been treated for diabetes was generated from the Seoul National University Bundang Hospital database using diagnosis code and prescribed medication during 2004. The 4474 patients were classified into three groups according to the baseline HbA1c in 2004 (HbA1c < 6.50%, 6.507.49% and < 7.50%; termed groups 1, 2 and 3, respectively). The outcomes were extracted from the database of Statistics Korea for mortality and registry in the Korean Society of Nephrology for ESRD incidence.Results. Ninety patients developed ESRD during 5.29 ± 1.22 years of mean follow-up period. Group 1 patients showed the lowest incidence of ESRD (P = 0.003). Compared with this group, the adjusted hazard ratio of ESRD was 2.915 and 4.219 in groups 2 and 3, respectively. The incidence of ESRD increased in patients with HbA1c < 6.50% compared with the patients with HbA1c < 6.50%, regardless of GFR. However, HbA1c < 6.50% showed no benefit on ESRD development in patients older than 80 years and in patients with diabetic duration > 10 years. All-cause mortality was not associated with the level of HbA1c.Conclusions. HbA1c < 6.50% was associated with reduced development of ESRD in all patients and later stages of chronic kidney disease.

Original languageEnglish
Pages (from-to)2238-2244
Number of pages7
JournalNephrology Dialysis Transplantation
Volume26
Issue number7
DOIs
Publication statusPublished - 2011 Jul 1
Externally publishedYes

Fingerprint

Glycosylated Hemoglobin A
Chronic Kidney Failure
Incidence
Mortality
Glomerular Filtration Rate
Chronic Renal Insufficiency
Databases

Keywords

  • diabetes mellitus
  • end-stage renal disease
  • glycosylated
  • haemoglobin A

ASJC Scopus subject areas

  • Nephrology
  • Transplantation

Cite this

Oh, S. W., Kim, Y. C., Koo, H. S., Jin, D. C., Na, K. Y., Chae, D. W., ... Chin, H. J. (2011). Glycated haemoglobin and the incidence of end-stage renal disease in diabetics. Nephrology Dialysis Transplantation, 26(7), 2238-2244. https://doi.org/10.1093/ndt/gfq707

Glycated haemoglobin and the incidence of end-stage renal disease in diabetics. / Oh, Se Won; Kim, Yong Chul; Koo, Ho Seok; Jin, Dong Chan; Na, Ki Young; Chae, Dong Wan; Kim, Suhnggwon; Chin, Ho Jun.

In: Nephrology Dialysis Transplantation, Vol. 26, No. 7, 01.07.2011, p. 2238-2244.

Research output: Contribution to journalArticle

Oh, SW, Kim, YC, Koo, HS, Jin, DC, Na, KY, Chae, DW, Kim, S & Chin, HJ 2011, 'Glycated haemoglobin and the incidence of end-stage renal disease in diabetics', Nephrology Dialysis Transplantation, vol. 26, no. 7, pp. 2238-2244. https://doi.org/10.1093/ndt/gfq707
Oh, Se Won ; Kim, Yong Chul ; Koo, Ho Seok ; Jin, Dong Chan ; Na, Ki Young ; Chae, Dong Wan ; Kim, Suhnggwon ; Chin, Ho Jun. / Glycated haemoglobin and the incidence of end-stage renal disease in diabetics. In: Nephrology Dialysis Transplantation. 2011 ; Vol. 26, No. 7. pp. 2238-2244.
@article{eda8fefb5b054ae4b3fbdb494bdd3c60,
title = "Glycated haemoglobin and the incidence of end-stage renal disease in diabetics",
abstract = "Background. The relationship between glycated haemoglobin and the incidence of end-stage renal disease (ESRD) in patients with diabetes remains uncertain, especially in those with decreased glomerular filtration rate (GFR). The aim of this study was to assess the appropriate HbA1c level for diabetics for minimizing the incidence of ESRD and all-cause mortality.Methods. A cohort of patients aged 25 years or older who had been treated for diabetes was generated from the Seoul National University Bundang Hospital database using diagnosis code and prescribed medication during 2004. The 4474 patients were classified into three groups according to the baseline HbA1c in 2004 (HbA1c < 6.50{\%}, 6.507.49{\%} and < 7.50{\%}; termed groups 1, 2 and 3, respectively). The outcomes were extracted from the database of Statistics Korea for mortality and registry in the Korean Society of Nephrology for ESRD incidence.Results. Ninety patients developed ESRD during 5.29 ± 1.22 years of mean follow-up period. Group 1 patients showed the lowest incidence of ESRD (P = 0.003). Compared with this group, the adjusted hazard ratio of ESRD was 2.915 and 4.219 in groups 2 and 3, respectively. The incidence of ESRD increased in patients with HbA1c < 6.50{\%} compared with the patients with HbA1c < 6.50{\%}, regardless of GFR. However, HbA1c < 6.50{\%} showed no benefit on ESRD development in patients older than 80 years and in patients with diabetic duration > 10 years. All-cause mortality was not associated with the level of HbA1c.Conclusions. HbA1c < 6.50{\%} was associated with reduced development of ESRD in all patients and later stages of chronic kidney disease.",
keywords = "diabetes mellitus, end-stage renal disease, glycosylated, haemoglobin A",
author = "Oh, {Se Won} and Kim, {Yong Chul} and Koo, {Ho Seok} and Jin, {Dong Chan} and Na, {Ki Young} and Chae, {Dong Wan} and Suhnggwon Kim and Chin, {Ho Jun}",
year = "2011",
month = "7",
day = "1",
doi = "10.1093/ndt/gfq707",
language = "English",
volume = "26",
pages = "2238--2244",
journal = "Nephrology Dialysis Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "7",

}

TY - JOUR

T1 - Glycated haemoglobin and the incidence of end-stage renal disease in diabetics

AU - Oh, Se Won

AU - Kim, Yong Chul

AU - Koo, Ho Seok

AU - Jin, Dong Chan

AU - Na, Ki Young

AU - Chae, Dong Wan

AU - Kim, Suhnggwon

AU - Chin, Ho Jun

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Background. The relationship between glycated haemoglobin and the incidence of end-stage renal disease (ESRD) in patients with diabetes remains uncertain, especially in those with decreased glomerular filtration rate (GFR). The aim of this study was to assess the appropriate HbA1c level for diabetics for minimizing the incidence of ESRD and all-cause mortality.Methods. A cohort of patients aged 25 years or older who had been treated for diabetes was generated from the Seoul National University Bundang Hospital database using diagnosis code and prescribed medication during 2004. The 4474 patients were classified into three groups according to the baseline HbA1c in 2004 (HbA1c < 6.50%, 6.507.49% and < 7.50%; termed groups 1, 2 and 3, respectively). The outcomes were extracted from the database of Statistics Korea for mortality and registry in the Korean Society of Nephrology for ESRD incidence.Results. Ninety patients developed ESRD during 5.29 ± 1.22 years of mean follow-up period. Group 1 patients showed the lowest incidence of ESRD (P = 0.003). Compared with this group, the adjusted hazard ratio of ESRD was 2.915 and 4.219 in groups 2 and 3, respectively. The incidence of ESRD increased in patients with HbA1c < 6.50% compared with the patients with HbA1c < 6.50%, regardless of GFR. However, HbA1c < 6.50% showed no benefit on ESRD development in patients older than 80 years and in patients with diabetic duration > 10 years. All-cause mortality was not associated with the level of HbA1c.Conclusions. HbA1c < 6.50% was associated with reduced development of ESRD in all patients and later stages of chronic kidney disease.

AB - Background. The relationship between glycated haemoglobin and the incidence of end-stage renal disease (ESRD) in patients with diabetes remains uncertain, especially in those with decreased glomerular filtration rate (GFR). The aim of this study was to assess the appropriate HbA1c level for diabetics for minimizing the incidence of ESRD and all-cause mortality.Methods. A cohort of patients aged 25 years or older who had been treated for diabetes was generated from the Seoul National University Bundang Hospital database using diagnosis code and prescribed medication during 2004. The 4474 patients were classified into three groups according to the baseline HbA1c in 2004 (HbA1c < 6.50%, 6.507.49% and < 7.50%; termed groups 1, 2 and 3, respectively). The outcomes were extracted from the database of Statistics Korea for mortality and registry in the Korean Society of Nephrology for ESRD incidence.Results. Ninety patients developed ESRD during 5.29 ± 1.22 years of mean follow-up period. Group 1 patients showed the lowest incidence of ESRD (P = 0.003). Compared with this group, the adjusted hazard ratio of ESRD was 2.915 and 4.219 in groups 2 and 3, respectively. The incidence of ESRD increased in patients with HbA1c < 6.50% compared with the patients with HbA1c < 6.50%, regardless of GFR. However, HbA1c < 6.50% showed no benefit on ESRD development in patients older than 80 years and in patients with diabetic duration > 10 years. All-cause mortality was not associated with the level of HbA1c.Conclusions. HbA1c < 6.50% was associated with reduced development of ESRD in all patients and later stages of chronic kidney disease.

KW - diabetes mellitus

KW - end-stage renal disease

KW - glycosylated

KW - haemoglobin A

UR - http://www.scopus.com/inward/record.url?scp=79959941662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959941662&partnerID=8YFLogxK

U2 - 10.1093/ndt/gfq707

DO - 10.1093/ndt/gfq707

M3 - Article

C2 - 21098657

AN - SCOPUS:79959941662

VL - 26

SP - 2238

EP - 2244

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

SN - 0931-0509

IS - 7

ER -